Last €7.61 EUR
Change Today +0.011 / 0.14%
Volume 7.0M
SAN On Other Exchanges
Symbol
Exchange
Xetra
Continuous
London
EN Amsterdam
BrsaItaliana
Mexico
New York
OTC US
Frankfurt
Continuous
As of 5:16 AM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark Christopher Capone

President of Myriad Genetic Laboratories Inc, Myriad Genetics Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 3 different industries.

See Board Relationships
52$4,062,470
As of Fiscal Year 2013

Background*

Mr. Mark Christopher Capone has been the President of Myriad Genetic Laboratories, Inc. since March 1, 2010. Mr. Capone served as the Chief Operating Officer of Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. since February 2006. Mr. Capone served as Senior Vice President of Sales at Myriad Genetics Inc. from October 2002 to 2006. Prior to joining Myriad, Mr. Capone served 17 years with Eli Lilly and Company, where he held positions as Product ...

Read Full Background

Corporate Headquarters*

Ciudad Grupo Santander
Madrid, Madrid 28660

Spain

Phone: 34 90 211 22 11
Fax: --

Board Members Memberships*

2010-Present
Director, Member of Audit Committee and Member of Nominating & Governance Committee

Education*

MS
Massachusetts Institute of Technology
BS
Pennsylvania State University

Other Affiliations*

Annual Compensation*

Salary$546,104
Bonus$505,812
Total Annual Compensation$1,051,916

Stock Options*

All Other Compensation$10,254
Exercised Options224,304
Exercised Options Value$3,591,090
Exercisable Options400,251
Exercisable Options Value$1,542,855
Unexercisable Options641,750
Unexercisable Options Value$2,408,985
Total Value of Options$7,542,930
Total Number of Options1,266,305

Total Compensation*

Total Annual Cash Compensation$1,062,170
Total Short Term Compensation$1,051,916
Other Long Term Compensation$10,254
Total Calculated Compensation$4,062,470
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAN:SM €7.60 EUR +0.008

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Joseph A. Chlapaty Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Advanced Drainage Systems, Inc.
$454.2K
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
$1.2M
Russell Cummings Chief Executive Officer, Executive Director, and Member of Investment Committee
Imperial Innovations Group plc
210.0K GBP
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Michael J. Pellini M.D., MBAChief Executive Officer, President and Director
Foundation Medicine, Inc.
$403.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BANCO SANTANDER SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.